Theravance Biopharma Stock Forecast - Total Risk Alpha
| TBPH Stock | USD 9.47 0.14 1.46% |
Theravance Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Theravance Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
Theravance |
| Check Theravance Biopharma Volatility | Backtest Theravance Biopharma | Information Ratio |
Theravance Biopharma Trading Date Momentum
| On November 25 2024 Theravance Biopharma was traded for 9.47 at the closing time. The top price for the day was 9.75 and the lowest listed price was 9.37 . There was no trading activity during the period 0.0. Lack of trading volume on November 25, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 1.27% . |
| Compare Theravance Biopharma to competition |
Other Forecasting Options for Theravance Biopharma
For every potential investor in Theravance, whether a beginner or expert, Theravance Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Theravance Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Theravance. Basic forecasting techniques help filter out the noise by identifying Theravance Biopharma's price trends.Theravance Biopharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Theravance Biopharma stock to make a market-neutral strategy. Peer analysis of Theravance Biopharma could also be used in its relative valuation, which is a method of valuing Theravance Biopharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Theravance Biopharma Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Theravance Biopharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Theravance Biopharma's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Theravance Biopharma Market Strength Events
Market strength indicators help investors to evaluate how Theravance Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Theravance Biopharma shares will generate the highest return on investment. By undertsting and applying Theravance Biopharma stock market strength indicators, traders can identify Theravance Biopharma entry and exit signals to maximize returns.
Theravance Biopharma Risk Indicators
The analysis of Theravance Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Theravance Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting theravance stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.48 | |||
| Semi Deviation | 1.4 | |||
| Standard Deviation | 2.06 | |||
| Variance | 4.24 | |||
| Downside Variance | 2.72 | |||
| Semi Variance | 1.96 | |||
| Expected Short fall | (1.74) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether Theravance Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Theravance Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Theravance Biopharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Theravance Biopharma Stock:Check out Historical Fundamental Analysis of Theravance Biopharma to cross-verify your projections. For more detail on how to invest in Theravance Stock please use our How to Invest in Theravance Biopharma guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Theravance Biopharma. If investors know Theravance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Theravance Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.03) | Revenue Per Share 1.293 | Quarterly Revenue Growth 0.075 | Return On Assets (0.06) | Return On Equity (0.23) |
The market value of Theravance Biopharma is measured differently than its book value, which is the value of Theravance that is recorded on the company's balance sheet. Investors also form their own opinion of Theravance Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Theravance Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Theravance Biopharma's market value can be influenced by many factors that don't directly affect Theravance Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Theravance Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Theravance Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Theravance Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.